Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

11.15
BATS BZX Real-Time Price
As of 10:14am ET
 -0.15 / -1.33%
Today’s Change
6.00
Today|||52-Week Range
12.98
+6.60%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close11.30
Today’s open11.10
Day’s range11.10 - 11.20
Volume1,969
Average volume (3 months)342,326
Market cap$457.8M
Dividend yield--
Data as of 10:14am ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)+78.18%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book6.52

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc-0.55-4.12%
OTICOtonomy Inc-0.60-3.70%
OMEROmeros Corp-0.51-4.59%
NERVMinerva Neuroscience...-0.50-3.70%
Data as of 10:14am ET, 12/07/2016

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs